Six frameworks. One evidence system.

Medical device companies do not get to choose which regulations apply to their software.

FDA Section 524B is the floor. IEC 62304, EU MDR, ISO 14971, HIPAA, and NIST SSDF run in parallel — each with its own evidence requirements, its own submission deadline, and its own consequence for non-conformity. X-DLM™ integrates Siemens Polarion and Black Duck to produce the evidence each framework requires, as a byproduct of normal engineering and regulatory operations.

Submission Rejection

A missing SBOM doesn't delay your 510(k). It stops it.

FDA Technical Screening holds from missing or non-compliant cybersecurity documentation reset your review clock entirely — adding 90+ days minimum to your clearance timeline and deferring your market access window.

Market Disqualification

35% of hospital procurement teams won't consider a device without an SBOM.

SBOM absence now accounts for 34% of hospital device rejection decisions. For manufacturers without SBOM capability, that is an effective disqualifier in more than a third of the procurement market. Source: RunSafe 2026.

56% of hospital procurement teams have rejected a device on cybersecurity grounds. Up from 46% last year.

56%

Of hospital procurement organizations have rejected a device on cybersecurity grounds. Source: RunSafe Medical Device Cybersecurity Index 2026.

317K+

Known vulnerabilities in Black Duck's KnowledgeBase — with 63,000+ exclusive BDSA advisories not found in NVD.

72%

Of medical device manufacturers struggle to produce compliant SBOMs due to complex third-party and open-source software dependencies.

15%

Of 510(k) submissions receive a Technical Screening hold. Cybersecurity documentation gaps are among the top causes.

3 weeks

BDSA advisories ahead of NVD — critical lead time for SOUP component vulnerability response in IEC 62304 Class B/C software.

Medical device software answers to six frameworks — simultaneously.

RegulationWho it affectsTimingWhat you must answerHow X-DLM™ helps
FDA Section 524BMedical device manufacturers submitting premarket applications (510(k), PMA, De Novo) for 'cyber devices' — any device that can connect to the internet, contains software, or is vulnerable to cybersecurity threats.In force since March 29, 2023. FDA actively issuing Technical Screening holds and Refuse to Accept determinations. June 2025 guidance added updated SBOM and eSTAR requirements.Machine-readable SBOM (SPDX or CycloneDX, NTIA minimum elements), postmarket vulnerability management plan, threat model, secure product development evidence, coordinated vulnerability disclosure policy, SBOM update procedure.Black Duck generates SPDX/CycloneDX SBOMs aligned to NTIA requirements. X-DLM™ version-controls SBOMs in Polarion and links them to vulnerability decisions, build records, and release evidence. Postmarket surveillance evidence built continuously.
IEC 62304Medical device software teams globally — Class A, B, and C software. Required for FDA 21 CFR 820 / QMSR and EU MDR/IVDR submissions.Ongoing — required for every new device and major software modification. FDA QMSR transition mandatory as of February 2026.SOUP identification and management, software development lifecycle documentation, requirements traceability, unit and integration test records, software hazard analysis, change control, configuration management, Design History File.Polarion links requirements through architecture, code, static analysis, test cases, test results, SOUP records, and release documentation. Black Duck identifies every SOUP component. X-DLM™ routes SOUP change control through governed Polarion workflows.
EU MDR (EU 2017/745)Medical device manufacturers placing devices on the EU/EEA market — including software as a medical device (SaMD). Note: EU CRA does NOT apply to medical devices; EU MDR governs.Ongoing — full enforcement across device classes. Notified body capacity constraints making early Technical File preparation critical.Technical File with clinical evidence, risk management file (ISO 14971), design and manufacturing documentation, post-market surveillance plan, labeling, Declaration of Conformity, Unique Device Identification (UDI).Polarion maintains the Technical File structure throughout the product lifecycle — requirements, risk management links, design documentation, verification and validation records, and post-market surveillance evidence. All traceable, version-controlled, and exportable.
ISO 14971All medical device manufacturers — required for both FDA 21 CFR 820 and EU MDR conformity.Ongoing — integrated into product development lifecycle from concept through post-market.Hazard identification, risk estimation, risk evaluation, risk control, residual risk assessment, benefit-risk analysis, risk management report, post-production information tracking.Polarion links software hazard analysis, risk control measures, verification activities, and post-market surveillance signals. Black Duck vulnerability findings are linked to ISO 14971 risk records for cybersecurity risk management documentation.
HIPAA Security RuleMedical device software that processes, stores, or transmits electronic Protected Health Information (ePHI) — including connected diagnostic, monitoring, and therapeutic devices.Ongoing — HHS OCR actively enforcing. Per-violation penalties up to $1.9M/year.Administrative, physical, and technical safeguards for ePHI. Access controls, audit controls, integrity controls, transmission security, risk analysis, workforce training, security incident procedures.Black Duck identifies vulnerable components in ePHI-handling software. X-DLM™ routes security findings through Polarion with HIPAA safeguard mapping, remediation ownership, and audit-ready response records.
NIST SP 800-218 (SSDF)Medical device manufacturers selling to US federal healthcare buyers (VA, DoD health systems, CMS systems) or seeking FedRAMP authorization for connected device cloud components.Active federal procurement requirement. Referenced in FDA guidance as a recommended Secure Product Development Framework (SPDF) for Section 524B conformity.Secure development practices, vulnerability management, SBOM provision, provenance tracking, third-party component control, evidence of process maturity.Black Duck generates SPDX/CycloneDX SBOMs and supplies component intelligence. Polarion maintains SSDF lifecycle evidence. X-DLM™ synchronizes both for FDA SPDF evidence and federal procurement requirements.

From Black Duck SOUP detection to FDA submission-ready evidence.

  • 01

    Detect

    Black Duck scans source, binaries, containers, and firmware — identifying every SOUP component, vulnerability, license conflict, malware signal, and AI-generated code snippet with provenance risk.

  • 02

    Route

    X-DLM™ synchronizes findings into Polarion as governed work items — with IEC 62304 Class mapping, assigned owners, risk assessment links, escalation timelines, and approval chains.

  • 03

    Trace

    Findings are linked to requirements, architecture, code, test cases, test results, SOUP records, ISO 14971 risk controls, and release evidence — the IEC 62304 and FDA Design History File chain.

  • 04

    Submit

    LiveDocs and Polarion workflow history produce the FDA 524B cybersecurity evidence package, EU MDR Technical File sections, and IEC 62304 SOUP records on demand — for submission, notified body review, or hospital procurement RFP.

One evidence system for every framework.

Book a walkthrough of how X-DLM™ operationalizes FDA 524B, IEC 62304, EU MDR, ISO 14971, HIPAA, and NIST SSDF evidence in medical device software development — on Siemens Polarion and Black Duck.